MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic dysfunction"

  • 2026 International Congress

    Sudomotor Dysfunction in Patients With Normal and Abnormal Cardiac MIBG

    Z. Jiang, G. Chiaro, V. Iodice (London, United Kingdom)

    Objective: We examined the pattern of sweat loss in patients with normal versus abnormal MIBG and considered the implications of this in predicting phenoconversion trajectory.…
  • 2026 International Congress

    The Unholy Marriage Between Ogilvie Syndrome and Parkinson’s Disease

    Y. Zashchypas, S. Lorenzl (Salzburg, Austria)

    Objective: To demonstrate the dynamic interplay between advanced Parkinson’s disease (PD)–related colonic dysmotility and acute colonic pseudo-obstruction (ACPO; Ogilvie syndrome) and to highlight practical red…
  • 2026 International Congress

    A prospective single-center study investigating the utility of supportive features in the diagnosis of multiple system atrophy with predominant cerebellar ataxia

    A. Sugiyama, Y. Nakagawa, M. Namiki, S. Hirano, Y. Nakano, T. Yamamoto, Y. Yamanaka, M. Mori (Chiba, Japan)

    Objective: The present study aimed to determine the utility of supportive motor and nonmotor features in differentiating multiple system atrophy (MSA) with predomainat cerebellar ataxia…
  • 2026 International Congress

    Movement Disorder Phenotypes in Neuronal Antibody–Mediated Autoimmune Encephalitis

    N. Nasrkhani*, N. Tahsin*, D. Dash (Toronto, Canada)

    Objective: To characterize movement disorder phenotypes in neuronal antibody–mediated autoimmune encephalitis (AE) and assess associations with specific antibody subtypes. Background: Neuronal antibody–mediated AE is a…
  • 2026 International Congress

    Pattern and progression of sudomotor dysfunction in alpha synucleinopathies

    Z. Jiang, G. Chiaro, V. Iodice (London, United Kingdom)

    Objective: This study examined the distribution and longitudinal progression of sweat loss in patients with PAF. Background: Pure autonomic failure (PAF) is an alpha-synucleinopathy with…
  • 2026 International Congress

    Structural validity, reliability, and minimally important differences for the SCOPA-AUT

    D. González, A. Karstens, G. Springer, A. Mahajan (Chicago, USA)

    Objective: To determine the structural validity, reliability, and minimally important difference values for the SCOPA-AUT. Background: Autonomic dysfunction is common in Parkinson’s disease (PD). A…
  • 2026 International Congress

    Expanding the Spectrum of Non Motor Symptoms in Dystonia: Focus on Autonomic Signs and Pain

    P. Antenucci, F. Colucci, A. Gozzi, A. Mechelli, M. Fraccalanza, F. Rovito, M. Pugliatti, E. Sette, D. Gragnaniello, M. Sensi (Ferrara, Italy)

    Objective: To assess autonomic nervous system (ANS) involvement and pain prevalence among non-motor symptoms (NMS) in different types of dystonia Background: Prevalence and functional impact…
  • 2026 International Congress

    Clinicodemographic characterization of Multiple System Atrophy in a multi-ethnic Malaysian cohort

    JWY. Tee, AMF. Dy Closas, RJ. Neo, AL. Lee, AM. Abdul Sahak, YY. Beh, JP. Schee, P. Gengadharan, YW. Tay, TS. Toh, SH. Mat Desa, SY. Lim, N. Mohammad Ibrahim, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To characterize the clinico-demographic features of multiple system atrophy (MSA) patients in a multiethnic Malaysian cohort. Background: MSA is a rare and rapidly progressive…
  • 2026 International Congress

    The Nature of autonomic dysfunction and its relationship with motor symptoms in Drug-Naive Parkinson’s Disease Patients: Korean Cohort Data

    YS. Hwang, J. Park, JM. Seok (Jeonju, Republic of Korea)

    Objective: We aimed to characterize the domain-specific distribution of autonomic symptoms in newly diagnosed, drug-naive PD and to investigate whether distinct autonomic patterns are associated…
  • 2026 International Congress

    Impact of foslevodopa/foscarbidopa infusion on autonomic symptoms in advanced Parkinson’s Disease

    D. Rinaldi, L. de Carolis, E. Bianchini, S. Galli, M. Salvetti (Rome, Italy)

    Objective: To investigate the impact of continuous subcutaneous foslevodopa/foscarbidopa infusion (CSFLI) on autonomic symptoms in patients with advanced Parkinson’s disease (aPD) Background: CSFLI is a…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley